Literature DB >> 27118872

Health-related quality of life in different stages of chronic kidney disease.

H K Aggarwal1, D Jain2, S Pawar1, R K Yadav1.   

Abstract

INTRODUCTION: Improved survival of chronic kidney disease (CKD) patients has led to an increased focus on health-related quality of life (HRQoL) for evaluating treatment effectiveness and assessing health outcomes of these patients.
OBJECTIVE: To evaluate HRQoL in patients in different stages of CKD and to explore possible correlating and influencing factors.
METHODS: Cross-sectional design with 200 patients from India in CKD stages 1-5 assessed for HRQoL through 36-item short-form together with biomarkers. Patients were divided into four groups according to their estimated Glomerular Filtration Rate (eGFR); group A with GFR range > 90 ml/min/1.73 m2, group B with GFR range 30-59 ml/min/1.73 m2, group C with GFR range 15-29 ml/min/1.73 m2 and group D with GFR < 15 ml/min/1.73 m2
RESULTS: HRQoL scores in all dimensions impaired progressively and significantly across renal function levels and CKD stages. A statistically significant decreasing trend in physical composite summary and mental composite summary scores was found in patients from group A to D (P< 0.001). Patients with eGFR < 30 ml/min/1.73 m2, Diabetes Mellitus, Cardio vascular disease (CVD), C-reactive protein (CRP) ≥ 5 mg/l, Hemoglobin  ≤ 90 g/l, erythrocyte sedimentation rate  ≥ 20 and mean arterial pressure  ≥ 100 mm hg had significantly lower scores on all HRQoL dimensions. Among these CRP, reduced GFR and CVD were the most important predictors of impaired HRQoL.
CONCLUSION: Considering the worldwide growing prevalence of CKD and increasing importance of HRQoL in chronic diseases, improving our knowledge about HRQoL and its predictors in CKD patients is important. Assessment of HRQoL early in disease course will help to identify high risk patients in whom modifying these factors may help them lead an active and healthy life.
© The Author 2016. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27118872     DOI: 10.1093/qjmed/hcw054

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  13 in total

1.  Nonmedical Factors and Health-Related Quality of Life in CKD in India.

Authors:  Gopesh K Modi; Ashok K Yadav; Arpita Ghosh; Kajal Kamboj; Prabhjot Kaur; Vivek Kumar; Shobhit Bhansali; Narayan Prasad; Manisha Sahay; Sreejith Parameswaran; Santosh Varughese; Sishir Gang; Shivendra Singh; Dipankar Sircar; Natarajan Gopalakrishnan; Ajay Jaryal; Sanjay Vikrant; Seema Baid-Agrawal; Vivekanand Jha
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-30       Impact factor: 8.237

2.  Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease.

Authors:  Nicholas C Chesnaye; Yvette Meuleman; Esther N M de Rooij; Ellen K Hoogeveen; Friedo W Dekker; Marie Evans; Agneta A Pagels; Fergus J Caskey; Claudia Torino; Gaetana Porto; Maciej Szymczak; Christiane Drechsler; Christoph Wanner; Kitty J Jager
Journal:  Clin J Am Soc Nephrol       Date:  2022-01-24       Impact factor: 8.237

3.  New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice.

Authors:  Marc Evans; Angharad R Morgan; Martin B Whyte; Wasim Hanif; Stephen C Bain; Philip A Kalra; Sarah Davies; Umesh Dashora; Zaheer Yousef; Dipesh C Patel; W David Strain
Journal:  Drugs       Date:  2021-12-21       Impact factor: 9.546

4.  Health-Related Quality of Life according to Renal Function: Results from a Nationwide Health Interview and Examination Survey.

Authors:  Liv Faulhaber; Stefan Herget-Rosenthal; Hannes Jacobs; Falk Hoffmann
Journal:  Kidney Blood Press Res       Date:  2021-11-22       Impact factor: 2.687

5.  Determinants of quality of life as measured with variants of SF-36 in patients with predialysis chronic kidney disease.

Authors:  Mohammed M Alhaji; Jackson Tan; Mas Rwa Hamid; James A Timbuak; Lin Naing; Nik Aa Tuah
Journal:  Saudi Med J       Date:  2018-07       Impact factor: 1.484

6.  Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England.

Authors:  Nga T Q Nguyen; Paul Cockwell; Alexander P Maxwell; Matthew Griffin; Timothy O'Brien; Ciaran O'Neill
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

7.  Quality improvement at scale: evaluation of the drivers and barriers to adoption and sustainability of an intervention to reduce late referral in chronic kidney disease.

Authors:  Nicola Thomas; Michael Nation; Lesley Woolnough; Hugh Gallagher
Journal:  BMJ Open Qual       Date:  2020-11

8.  Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease.

Authors:  Edward Zimbudzi; Clement Lo; Sanjeeva Ranasinha; Gregory Fulcher; Martin Gallagher; Stephen Jan; Peter G Kerr; Helena J Teede; Kevan R Polkinghorne; Grant Russell; Rowan G Walker; Sophia Zoungas
Journal:  Health Qual Life Outcomes       Date:  2018-11-19       Impact factor: 3.186

9.  Correlation of sociodemographic profiles with psychological problems among hospitalized patients receiving unplanned hemodialysis.

Authors:  Yu-Yin Kao; Wen-Chin Lee; Ruey-Hsia Wang; Jin-Bor Chen
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 10.  SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.

Authors:  David C Wheeler; June James; Dipesh Patel; Adie Viljoen; Amar Ali; Marc Evans; Kevin Fernando; Debbie Hicks; Nicola Milne; Philip Newland-Jones; John Wilding
Journal:  Diabetes Ther       Date:  2020-09-29       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.